From the Journals

Cochrane report: HPV vaccine proves its worth in adolescent, young adult women


 

FROM THE COCHRANE LIBRARY


Several of the researchers received travel grants from GlaxoSmithKline or MSD-Sanofi-Pasteur.

SOURCE: Arbyn M et al. Cochrane Database Syst Rev. 2018. doi: 10.1002/14651858.CD009069.pub3.

Pages

Recommended Reading

The race is on for a Zika vaccine
MDedge ObGyn
Pregnant women’s access to vaccination website, social media improved infants’ up-to-date immunizations
MDedge ObGyn
Parents have diverse reasons for refusing HPV vaccine for their child
MDedge ObGyn
Biologics during pregnancy did not affect infant vaccine response
MDedge ObGyn
Adolescents with chronic health conditions often undervaccinated
MDedge ObGyn
Adacel Tdap effective throughout third trimester vaccination window
MDedge ObGyn
NIAID proposes 3-pronged plan for universal influenza vaccine
MDedge ObGyn
2 new influenza strains recommended for next season
MDedge ObGyn
Maternal biologic therapy does not affect infant vaccine responses
MDedge ObGyn
Phase 2 ‘universal flu vaccine’ trial announced
MDedge ObGyn